ABSTRACT NUMBER: ESOC2026A896 OPTIMAL TIMING FOR PHARMACOLOGICAL VTE PROPHYLAXIS IN TRAUMATIC BRAIN INJURY: A NETWORK META-ANALYSIS OF 13,173 PATIENTS
Nada Ahmed, Wesal Mahmoud, Alyaa Madeeh · 2026
Read ABSTRACT NUMBER: ESOC2026A896 OPTIMAL TIMING FOR PHARMACOLOGICAL VTE PROPHYLAXIS IN TRAUMATIC BRAIN INJURY: A NETWORK META-ANALYSIS OF 13,173 PATIENTS by Nada Ahmed, Wesal Mahmoud, Alyaa Madeeh (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13145981.txt.
Description
Nada Ahmed, Wesal Mahmoud, and Alyaa Madeeh present this 2026 conference abstract on the best time to start clot-preventing drugs after a traumatic brain injury. Patients with such injuries face a high risk of vein clots, yet doctors often delay the drugs for fear of worsening bleeding in the brain. The team pooled studies in a network analysis to compare start times.
Fourteen studies with 13,173 patients met the rules, drawn from four databases through December 2024. Starting the drugs within twenty-four to forty-eight hours cut the risks of leg vein clots, lung clots, and growth of brain bleeding in the pooled result. Death rates and overall clot rates did not differ clearly across start times. The authors flag the one-to-two-day window as the most promising and urge prompt starts when the brain bleed is stable.
Catalog record
| CREATOR | Nada Ahmed, Wesal Mahmoud, Alyaa Madeeh |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |